DESIPRAMINE IN TREATMENT OF PARKINSON'S DISEASE

This publication has 6 references indexed in Scilit:

• The influence of a tricyclic antidepressive agent (protriptyline) on some of the circulatory effects of noradrenaline and adrenaline in man
  Life Sciences, 1967
• Central effects of imipramine-like anti-depressants in relation to their peripheral anticholinergic activity
  International Journal of Neuropharmacology, 1967
• Imipramine in Treatment of Parkinsonism: a Double-blind Placebo Study
  BMJ, 1965
• Untersuchungen über den Einfluß von Desmethyl-Imipramin-Pertofran® auf den Parkinsonismus beim Menschen
  Archiv Fur Psychiatrie Und Nervenkrankheiten, 1965
• Isolation from rat brain of a metabolic product, desmethylimipramine, that mediates the antidepressant activity of imipramine (Tofranil)
  Cellular and Molecular Life Sciences, 1961
• Preliminary pharmacological and clinical results with desmethylimipramine (DMI) G 35020, a metabolite of imipramine
  Psychopharmacology, 1961